1/17
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Cephalosporins advantage
Cephalosporins have beta-lactam ring structure
Advantage over Penicillins - 7-methyl group in cephalosporins increases cephalosporin resistance to beta-lactamase
Moraxella catarrhalis DOC
second or third generation Cephalosporin
Neisseria gonorrhoeae DOC
ceftriaxone, cefixime
E. coli, Klebsiella, Proteus DOC
first or second generation Cephalosporin
Salmonella DOC
third generation Cephalosporin
Penicillin resistant Streptococcus pneumoniae DOC
ceftriaxone
Late Borrelia burgdorferi DOC
ceftriaxone
alternative for penicillin-allergic individuals
Cephalosporins, but caution about cross-reactivity
First Generation Cephalosporins
Good activity against G+ bacteria
relatively moderate activity against G- organisms (E. coli, Klebsiella, Proteus)
Renal excretion
cefazolin – DOC for surgical prophylaxis
Cefazolin – IV, IM
Cephalexin – oral
Cefadroxil - oral
Second Generation Cephalosporins
lower activity against G+
increased activity against G- negatives (E.coli, Moraxella, Klebsiella, Proteus)
Cefaclor- Oral
Cefuroxime- I.M., I.V.
Cefprozil- Oral
Cefoxitin- I.M., I.V.
Cefotetan- I.M., I.V.
Third Generation Cephalosporins
less active against G+ cocci
increased G- coverage
excellent activity against Enterobacteriaceae
most excreted by the kidney
Ceftriaxone- CNS penetration, Neisseria, Borrelia – IV/IM → Contraindication: neonates, bilirubin displacement
Cefotaxime Sodium- CNS penetration – IV/IM
Ceftazidime- P. aeruginosa – IV/IM
Cefpodoxime, Cefdinir, Cefixime- Oral
Fourth Generation Cephalosporins
better G+ coverage
more resistant to beta-lactamases
Antipseudomonal
Penetrates the CSF
renal excretion
broadest coverage of the class: Enterobacteriaceae, MSSA, Pseudomonas
empirical therapy, particularly when resistance to β-lactamases are suspected
Cefepime- IV
“Fifth” Generation Cephalosporins
activity against G+ and G-, approved for CABP
renal excretion
no antipseudomonal activity
MRSA and VRSA coverage: the only beta lactam active against MRSA
Mechanistically, ceftaroline can bind to PBP2A with very high affinity – this is the mutated PBP that other beta-lactams cannot bind to
Ceftaroline fosamil- IV
Cephalosporin Adverse Effects
superinfection
disulfiram-like reaction
Allergy (cross sensitivity with pen)
Dose dependent renal tubular necrosis
Diarrhea
Imipenem, Meropenem and Ertapenem
Carbapenems
Imipenem is rapidly inactivated by renal tubule dihydropeptidases and must be given with cilastatin, a dihydropeptidase inhibitor
Imipenem & Meropenem
I.V.
broad spectrum, including anaerobes, G+ and G-, Pseudomonas (good for mixed infections)
relatively resistant to β-lactamases
Imipenem can cause seizures and should be used cautiously in patients with renal failure, brain lesions, head trauma, or a history of CNS disorders such as seizures
meropenem is less likely to cause seizures
potential for penicillin cross-reactivity
Ertapenem
less active against Pseudomonas, should not be used
I.V. or I.M
95% protein binding
Aztreonam
Monobactam
active only against aerobic G- rods
IM or IV
relatively resistant to β-lactamases
few side effects (phlebitis, skin rash, abnormal liver function)
No cross sensitivity with other β-lactams (good for pen allergic)